Dashboard
Manage Tickers

ABMDABIOMED INC

Nasdaq abiomed.com


$ 381.19 $ 0.23 (0.06 %)    

Wednesday, 21-Dec-2022 15:59:52 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 381.02
$ 380.70 x 400
$ 388.84 x 100
-- - --
$ 219.85 - $ 381.99
20,612,257
na
17.42B
$ 1.20
$ 65.29
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-03-2022 09-30-2022 10-Q
2 08-04-2022 06-30-2022 10-Q
3 05-20-2022 03-31-2022 10-K
4 02-03-2022 12-31-2021 10-Q
5 10-28-2021 09-30-2021 10-Q
6 08-05-2021 06-30-2021 10-Q
7 05-21-2021 03-31-2021 10-K
8 02-04-2021 12-31-2020 10-Q
9 11-06-2020 09-30-2020 10-Q
10 08-06-2020 06-30-2020 10-Q
11 05-21-2020 03-31-2020 10-K
12 02-06-2020 12-31-2019 10-Q
13 10-31-2019 09-30-2019 10-Q
14 08-01-2019 06-30-2019 10-Q
15 05-23-2019 03-31-2019 10-K
16 02-05-2019 12-31-2018 10-Q
17 11-06-2018 09-30-2018 10-Q
18 08-02-2018 06-30-2018 10-Q
19 05-24-2018 03-31-2018 10-K
20 02-06-2018 12-31-2017 10-Q
21 11-02-2017 09-30-2017 10-Q
22 08-01-2017 06-30-2017 10-Q
23 05-25-2017 03-31-2017 10-K
24 02-03-2017 12-31-2016 10-Q
25 11-04-2016 09-30-2016 10-Q
26 08-03-2016 06-30-2016 10-Q
27 05-26-2016 03-31-2016 10-K
28 02-05-2016 12-31-2015 10-Q
29 11-04-2015 09-30-2015 10-Q
30 08-06-2015 06-30-2015 10-Q
31 05-28-2015 03-31-2015 10-K
32 01-30-2015 12-31-2014 10-Q
33 11-10-2014 09-30-2014 10-Q
34 08-06-2014 06-30-2014 10-Q
35 05-28-2014 03-31-2014 10-K
36 02-06-2014 12-31-2013 10-Q
37 11-08-2013 09-30-2013 10-Q
38 08-07-2013 06-30-2013 10-Q
39 05-28-2013 03-31-2013 10-K
40 02-06-2013 12-31-2012 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

abiomed-announces-fda-approves-impella-ecp-pivotal-heart-pump-and-first-patients-enrolled-in-pivotal-clinical-trial
Abiomed Announces FDA Approves Impella ECP...
12/21/2022 14:02:08

Abiomed (NASDAQ:ABMD) announces the United States Food and Drug Administration (FDA) has approved the version of Impella ECP th...

Core News & Articles
Steel Dynamics Set To Join S&P 500 Replaci...
12/19/2022 22:17:51

S&P MidCap 400 constituent Steel Dynamics Inc. (NASD:STLD) will replace Abiomed Inc. (NASD:ABMD) in the S&P 500 and Sup...

pfizer-novartis-are-among-overbought-healthcare-stocks-are-they-worth-a-look
Pfizer, Novartis Are Among Overbought Heal...
12/14/2022 13:23:25

The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies. Here’s t...

Core News & Articles
Johnson & Johnson Announced Extension of A...
12/14/2022 12:17:03

Johnson & Johnson (NYSE: JNJ), the world's largest, most diversified healthcare products company, today announced that ...

if-you-invested-100-in-this-stock-10-years-ago-you-would-have-2800-today
If You Invested $100 In This Stock 10 Year...
12/08/2022 16:02:42

fda-says-on-dec-5-approved-updated-labeling-for-the-impella-rp-system-based-on-the-pas-results-with-an-update-to-the-indications-for-use-statement
FDA Says On Dec. 5, Approved Updated Label...
12/05/2022 14:37:51

- Reuters

abiomed-announces-first-three-patients-in-the-world-have-been-treated-with-impella-rp-flex-with-smartassist-the-cos-newest-heart-pump-for-patients-experiencing-right-heart-failure
Abiomed Announces First Three Patients In ...
12/05/2022 13:13:25

analyst-forecasts-101-117share-offer-price-for-horizon-therapeutics-buyout
Analyst Forecasts $101-117/Share Offer Pri...
11/30/2022 18:52:36

heres-how-much-you-would-have-made-owning-abiomed-stock-in-the-last-15-years
Here's How Much You Would Have Made Owning...
11/21/2022 20:01:07

peering-into-abiomeds-recent-short-interest
Peering Into Abiomed's Recent Short Interest
11/17/2022 15:12:26

Abiomed's (NASDAQ:ABMD) short percent of float has risen 6.62% since its last report. The company recently reported that it...

will-investors-notice-exciting-sign-on-abiomeds-chart
Will Investors Notice Exciting Sign On Abi...
11/16/2022 14:49:27

heres-how-much-100-invested-in-abiomed-20-years-ago-would-be-worth-today
Here's How Much $100 Invested In Abiomed 2...
11/04/2022 15:39:16

Abiomed (NASDAQ:ABMD) has outperformed the market over the past 20 years by 18.13% on an annualized basis producing an average...

5-analysts-have-this-to-say-about-abiomed
5 Analysts Have This to Say About Abiomed
11/02/2022 18:08:02

Over the past 3 months, 5 analysts have published their opinion on Abiomed (NASDAQ:ABMD) stock. These analysts are typically e...

benzingas-top-ratings-upgrades-downgrades-for-november-2-2022
Benzinga's Top Ratings Upgrades, Downgrade...
11/02/2022 14:06:35

Upgrades

morgan-stanley-upgrades-abiomed-to-equal-weight-raises-price-target-to-380
Morgan Stanley Upgrades Abiomed to Equal-W...
11/02/2022 11:30:01

Morgan Stanley analyst Cecilia Furlong upgrades Abiomed (NASDAQ:ABMD) from Underweight to Equal-Weight and raises the price ...

deutsche-bank-downgrades-abiomed-to-hold-raises-price-target-to-388
Deutsche Bank Downgrades Abiomed to Hold, ...
11/02/2022 10:12:24

Deutsche Bank analyst Pito Chickering downgrades Abiomed (NASDAQ:ABMD) from Buy to Hold and raises the price target from $35...

why-harsco-shares-surged-over-22-here-are-80-biggest-movers-from-yesterday
Why Harsco Shares Surged Over 22%; Here Ar...
11/02/2022 09:07:52

Gainers

gartner-sony-uber-and-other-big-gainers-from-tuesday
Gartner, Sony, Uber And Other Big Gainers ...
11/02/2022 06:57:49

U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks ...

william-blair-downgrades-abiomed-to-market-perform
William Blair Downgrades Abiomed to Market...
11/01/2022 20:43:49

William Blair analyst Margaret Kaczor downgrades Abiomed (NASDAQ:ABMD) from Outperform to Market Perform.

what-to-watch-in-the-sp-biotech-etf-after-johnson--johnsons-166b-abiomed-deal
What To Watch In The S&P Biotech ETF After...
11/01/2022 20:28:13

As the exodus out of mega-cap technology stocks continues, investors and money managers are looking for other sectors to rotate...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION